17-Allylaminogeldanamycin

17-Allylaminogeldanamycin

Catalog Number:
L002234604BIO
Mfr. No.:
AA17307
Price:
Inquiry
  • Size:
    Quantity:
    Add to Cart:
    Add to Cart
      • Overview

        • 17-AAG is the first clinically tested hsp90 inhibitor that exhibits antitumor activity. Its antitumor effects are documented in vivo for various animal models, including erbB2-dependent breast cancer, prostate cancer models, and melanoma.

          Please contact us at for specific academic pricing.

      • Properties
        • Categories
          Protein Interactions
          Alternative Name
          17-Demethoxy-17-(2-propenylamino)geldanamycin; Telatinib; Tanespimycin; 17-AAG
          CAS Number
          75747-14-7
          Molecular Formula
          C31H43N3O8
          Molecular Weight
          585.69 g/mol
          MDL Number
          MFCD04973892
          Note
          There is no hazardous surcharge associated with this product.
          There is no special packaging charge associated with this product.

          * For research use only. Not for human or veterinary use

      • Reference

        • Smith-Jones (2007). Imaging. Comprehensive Medicinal Chemistry II, 659-677.
          Sausville (2008). Heat shock protein-90 directed therapeutics and target validation. Cancer Drug Design and Discovery, 336-350.

    MSDS

    Documents

    Specification

    We Also Recommend

    17-DMAG hydrochloride

    17-DMAG hydrochloride

    Alvespimycin hydrochloride

    Alvespimycin hydrochloride

    AT-13387

    AT-13387

    Bortezomib- Bio-X

    Bortezomib- Bio-X

    Bufalin

    Bufalin

    $378

    Celastrol

    Celastrol

    $260

    D,L-Sulforaphane

    D,L-Sulforaphane

    Dorsomorphin

    Dorsomorphin

    Entinostat

    Entinostat

    Fenretinide

    Fenretinide

    $180

    Flavopiridol

    Flavopiridol

    $180

    Geldanamycin

    Geldanamycin

    $480